ClassID:

96898

C07K14/47 - page 14 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#3901
20110287043
2011-11-24

Melanoma antigens and their use in diagnostic and therapeutic methods

#3902
20110287033
2011-11-24

Use of ferritin to treat iron disorders

#3903
20110287016
2011-11-24

Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer

#3904
20110286976
2011-11-24

Bi-specific fusion proteins for tissue repair

#3905
20110281260
2011-11-17

Ribonucleic acid binding motif protein 20 sequence variants

#3906
20110280898
2011-11-17

INHBB EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME

#3907
20110280798
2011-11-17

Cell penetrating peptides for intracellular delivery

#3908
20110277045
2011-11-10

Screening methods for compounds useful for treating pancreatic dysfunction

#3909
20110275541
2011-11-10

USE OF MULTIPLE RECOMBINATION SITES WITH UNIQUE SPECIFICITY IN COMBINATIONAL CLONING

#3910
20110275102
2011-11-10

ACTIVATION OF MUTATED RAC-PK

#3911
20110275073
2011-11-10

Method of detecting tumor-associated DNA in plasma or serum with a premalignant solid tumor

#3912
20110274749
2011-11-10

Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers

#3913
20110274708
2011-11-10

Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling

#3914
20110271357
2011-11-03

COLON DISEASE TARGETS AND USES THEREOF

#3915
20110269946
2011-11-03

PROTEIN SEPARATION DEVICE

#3916
20110269229
2011-11-03

METHODS OF INHIBITING VIRAL REPLICATION

#3917
20110269141
2011-11-03

TARGET PROTEIN AND TARGET GENE FOR DRUG DISCOVERY, AND SCREENING METHOD

#3918
20110269122
2011-11-03

Hereditary hemochromatosis gene

#3919
20110268757
2011-11-03

USE OF PHENOL-SOLUBLE MODULINS FOR VACCINE DEVELOPMENT

#3920
20110268701
2011-11-03

Stress-responsive induction of a therapeutic agent and methods of use

#3921
20110266675
2011-11-03

DIRECTIONAL SELF-ASSEMBLY OF BIOLOGICAL ELECTRICAL INTERCONNECTS

#3922
20110265197
2011-10-27

Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof

#3923
20110263817
2011-10-27

METAL-BINDING COMPOUNDS AND USES THEREFOR

#3924
20110263689
2011-10-27

AKT ligands and polynucleotides encoding AKT ligands

#3925
20110262471
2011-10-27

RAB6KIFL/KIF20A epitope peptide and vaccines containing the same

#3926
20110262353
2011-10-27

Muteins of hNGAL and related proteins with affinity for a given target

#3927
20110257601
2011-10-20

VEGF antagonist formulations for intravitreal administration

#3928
20110257101
2011-10-20

Catecholamine regulated protein

#3929
20110257036
2011-10-20

Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof

#3930
20110256544
2011-10-20

MOLECULES INTERACTING WITH CASL (MICAL) POLYNUCLEOTIDES, POLYPEPTIDES, AND METHODS OF USING THE SAME

#3931
20110256053
2011-10-20

Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases

#3932
20110252485
2011-10-13

Novel gene disruptions, compositions and methods relating thereto

#3933
20110251108
2011-10-13

METHODS AND MATERIALS RELATING TO STEM CELL GROWTH FACTOR-LIKE POLYPEPTIDES AND POLYNUCLEOTIDES

#3934
20110250630
2011-10-13

Motif-grafted hybrid polypeptides and uses thereof

#3935
20110250612
2011-10-13

Method for monitoring the regulatory activity of chromosome segregation

#3936
20110250234
2011-10-13

Immunogenic polypeptides encoded by MAGE minigenes and uses thereof

#3937
20110250186
2011-10-13

Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell1

#3938
20110247087
2011-10-06

Regulation of endogenous gene expression in cells using zinc finger proteins

#3939
20110245147
2011-10-06

Activation of peptide prodrugs by hK2

#3940
20110245146
2011-10-06

Non-viral delivery of compounds to mitochondria

#3941
20110245096
2011-10-06

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

#3942
20110245090
2011-10-06

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

#3943
20110244500
2011-10-06

Gel electrophoresis method useful for resolution and characterization of nerve tissue ultra high molecular weight protein aggregates

#3944
20110244491
2011-10-06

Method for detecting human BPLP protein or a maturation product thereof

#3945
20110243930
2011-10-06

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

#3946
20110240012
2011-10-06

RECOMBINANT HUMAN CC10 AND COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF NASAL RHINITIS

#3947
20110239318
2011-09-29

METHODS FOR PRODUCING FISH WITH HIGH LIPID CONTENT

#3948
20110237777
2011-09-29

Fusion protein containing a single-stranded DNA binding protein and methods for expression and purification of the same

#3949
20110236973
2011-09-29

Centrosome proteins and uses thereof

#3950
20110236412
2011-09-29

Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine

#3951
20110236406
2011-09-29

IMMUNOGENIC COMPOSITIONS COMPRISING HMGB1 POLYPEPTIDES

#3952
20110236389
2011-09-29

Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof

#3953
20110236385
2011-09-29

Blocking mesothelin peptide fragments

#3954
20110230545
2011-09-22

EML4-ALK fusion gene

#3955
20110229878
2011-09-22

HUMAN CONSENSUS SODIUM-IODIDE SYMPORTER REPRESSOR (NIS-REPRESSOR) BINDING SITE

#3956
20110229552
2011-09-22

NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGIN

#3957
20110224415
2011-09-15

Human MutY

#3958
20110224279
2011-09-15

ANTICANCER AGENT

#3959
20110223609
2011-09-15

Gene defects and mutant ALK kinase in human solid tumors

#3960
20110223173
2011-09-15

Methods for reducing botulinum neurotoxin A toxicity

#3961
20110223149
2011-09-15

PEPTIDOMIMETIC MACROCYCLES

#3962
20110218122
2011-09-08

Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides

#3963
20110217314
2011-09-08

Methods and Compositions for Modulating Apoptosis

#3964
20110212903
2011-09-01

Metal-binding compounds and uses therefor

#3965
20110212902
2011-09-01

Metal-binding compounds and uses therefor

#3966
20110212449
2011-09-01

Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues

#3967
20110212107
2011-09-01

Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

#3968
20110212076
2011-09-01

Viral Therapeutic

#3969
20110212051
2011-09-01

VARIANTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR AND USE THEREOF

#3970
20110209248
2011-08-25

Sugar transporters

#3971
20110207914
2011-08-25

Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses

#3972
20110207911
2011-08-25

POLYPEPTIDE DERIVED FROM THE RYANODINE RECEPTOR THAT INHIBITS CALCIUM LEAKAGE

#3973
20110207801
2011-08-25

Novel Genes, Compositions, and Methods for Modulating the Unfolded Protein Response

#3974
20110207668
2011-08-25

Binding proteins inhibiting the VEGF-A receptor interaction

#3975
20110207171
2011-08-25

Oligosaccharide modification and labeling of proteins

#3976
20110207130
2011-08-25

Method of detecting tumor-associated hypermethylated DNA in plasma or serum

#3977
20110206755
2011-08-25

METHODS AND PRODUCTS FOR MANIPULATING UNCOUPLING PROTEIN EXPRESSION

#3978
20110201782
2011-08-18

Human genes relating to respiratory diseases and obesity

#3979
20110201560
2011-08-18

Peptides for inhibiting the HPV-E6 oncoprotein

#3980
20110201518
2011-08-18

Healthy kidney biomarkers

#3981
20110201105
2011-08-18

LACTATION-ASSOCIATED POLYPEPTIDES

#3982
20110201104
2011-08-18

ANTIVIRAL AGENT AGAINST ANIMAL VIRUSES

#3983
20110201055
2011-08-18

Engineered cleavage half-domains

#3984
20110201052
2011-08-18

Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer

#3985
20110197291
2011-08-11

Endoplasmic reticulum localization signals

#3986
20110196128
2011-08-11

Murine zcytor17 ligand polynucleotides

#3987
20110195908
2011-08-11

PROSAPOSIN AS A NEUROTROPHIC FACTOR

#3988
20110195504
2011-08-11

Tubulo-vesicular structure localization signals

#3989
20110195478
2011-08-11

BLADDER CANCER BIOMARKER AND TEST METHOD USING THE SAME

#3990
20110195407
2011-08-11

NUCLEIC ACID OCCURRING IN BLOOD FROM HEPATITIS PATIENT, POLYPEPTIDE ENCODED BY THE NUCLEIC ACID, AND USES OF THE SAME

#3991
20110195019
2011-08-11

Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer

#3992
20110191865
2011-08-04

Novel Gene Disruptions, Compositions and Methods Relating Thereto

#3993
20110190474
2011-08-04

Antimicrobial peptides and derived metapeptides

#3994
20110190224
2011-08-04

Non-viral delivery of compounds to mitochondria

#3995
20110190223
2011-08-04

HEMCM42 NUCLEIC ACIDS

#3996
20110190144
2011-08-04

NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF PSORIASIS

#3997
20110190138
2011-08-04

Methods and compositions for treating conditions

#3998
20110189774
2011-08-04

Plant centromere compositions

#3999
20110189731
2011-08-04

Polynucleotides encoding recombinant lubricin molecules and uses thereof

#4000
20110189237
2011-08-04

Therapeutic agent for malignant mesothelioma and immunostimulant

#4001
20110189214
2011-08-04

CDCA1 epitope peptides and vaccines containing the same

#4002
20110189193
2011-08-04

CELL LINES AND HOST NUCLEIC ACID SEQUENCES RELATED TO INFECTIOUS DISEASE

#4003
20110189097
2011-08-04

Use of WNT inhibitor to inhibit angiogenesis in the CNS

#4004
20110184153
2011-07-28

Modified gherlin peptides

#4005
20110183425
2011-07-28

Protein Complexes and Screening Methods

#4006
20110182921
2011-07-28

REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF

#4007
20110182879
2011-07-28

Human transferase family members and uses thereof

#4008
20110182875
2011-07-28

Class of therapeutic protein based molecules

#4009
20110178160
2011-07-21

Inhibition of interaction of PSD93 and PSDS95 with nNOS and NMDA receptors

#4010
20110178021
2011-07-21

OPIORPHIN FOR USE AS A PSYCHOSTIMULANT AGENT

#4011
20110177998
2011-07-21

Bioactive peptides and methods of using same

#4012
20110177972
2011-07-21

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

#4013
20110177554
2011-07-21

Fragments of secreted frizzled related protein

#4014
20110177082
2011-07-21

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER

#4015
20110177065
2011-07-21

METHODS OF TREATING/PREVENTING INFLAMMATION USING COMBINATION OF IL-1 ANTAGONIST AND IL-18 BINDING PROTEIN

#4016
20110172170
2011-07-14

INTERFERON-LIKE PROTEIN ZCYTO21

#4017
20110172148
2011-07-14

Periostin-induced pancreatic regeneration

#4018
20110172114
2011-07-14

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

#4019
20110171687
2011-07-14

Unstructured recombinant polymers and compositions comprising same

#4020
20110171666
2011-07-14

Peptide-lipid constructs and their use in diagnostic and therapeutic applications

#4021
20110171242
2011-07-14

LIGAND FOR HERPES SIMPLEX VIRUS ENTRY MEDIATOR AND METHODS OF USE

#4022
20110171238
2011-07-14

NOVEL STRA6 POLYPEPTIDES

#4023
20110171205
2011-07-14

NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR

#4024
20110171179
2011-07-14

Method for Regulating Production of Hemoglobin Beta Chains

#4025
20110171160
2011-07-14

POLYMER CONJUGATES OF KISS1 PEPTIDES

#4026
20110166066
2011-07-07

CATESTATIN (CST) AND ITS VARIANTS FOR TREATMENT OF CARDIOVASCULAR AND METABOLIC DISORDERS

#4027
20110165613
2011-07-07

STABLE CLONE CELL EXPRESSING A PRION

#4028
20110165165
2011-07-07

Nucleic acid encoding TNFx protein

#4029
20110165147
2011-07-07

NOVEL 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 AND 26908 MOLECULES AND USES THEREFOR

#4030
20110165066
2011-07-07

Interleukin-13 binding proteins

#4031
20110159112
2011-06-30

Recombinant alpha-fetoprotein and compositions thereof

#4032
20110158908
2011-06-30

CYCLOSPORIN A-BINDING PROTEIN

#4033
20110158905
2011-06-30

Dock-and-lock (DNL) complexes for therapeutic and diagnostic use

#4034
20110154510
2011-06-23

Automated high-content live animal drug screening using

#4035
20110152199
2011-06-23

CDCA1 peptide and pharmaceutical agent comprising the same

#4036
20110151579
2011-06-23

Secreted Epithelial Stromal-1 Molecules and Uses Thereof

#4037
20110151487
2011-06-23

Compositions and methods for the treatment of cancer

#4038
20110151473
2011-06-23

Polynucleotides and Polypeptides Encoding Receptors

#4039
20110150919
2011-06-23

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#4040
20110150910
2011-06-23

METHODS OF INDUCING AN IMMUNE RESPONSE

#4041
20110150883
2011-06-23

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER

#4042
20110150882
2011-06-23

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER

#4043
20110150860
2011-06-23

NOVEL 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 AND 49933 MOLECULES AND USES THEREFOR

#4044
20110144308
2011-06-16

COMPOSITIONS AND METHODS FOR HUMANIZATION AND OPTIMIZATION OF N-GLYCANS IN PLANTS

#4045
20110143436
2011-06-16

Compositions and methods for reprogramming eukaryotic cells

#4046
20110143397
2011-06-16

RNA preparations comprising purified modified RNA for reprogramming cells

#4047
20110142919
2011-06-16

Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer

#4048
20110142868
2011-06-16

Peptidylarginine deiminase (PAD) inhibitors

#4049
20110142843
2011-06-16

Fetal polypeptides from human liver

#4050
20110136740
2011-06-09

Cystine knot peptides binding to alpha IIb beta 3 integrins and methods of use

#4051
20110136737
2011-06-09

DPP-IV resistant GIP hybrid polypeptides with selectable properties

#4052
20110136111
2011-06-09

Nucleic acid ligands against infectious prions

#4053
20110136108
2011-06-09

XBP1(S) Protein Acting as an Adipocyte Differentiation Marker Having a Facility to Regulate Differentiation into Adipocytes, and an Application Therefor

#4054
20110135675
2011-06-09

Melanoma associated peptide analogues and vaccines against melanoma

#4055
20110135647
2011-06-09

Genes and polypeptides relating to breast cancers

#4056
20110135620
2011-06-09

Prodrug activation in cancer cells using molecular switches

#4057
20110131669
2011-06-02

Ganglioside epitopes for treating guillain-barre syndrome

#4058
20110130343
2011-06-02

Immunity-inducing agent and method for detection of cancer

#4059
20110130341
2011-06-02

Method and kit for detection of cancer, and therapeutic agent for cancer

#4060
20110130335
2011-06-02

THERAPEUTIC AGENT AND TEST AGENT FOR DISEASE WITH MYOCARDIAL NECROSIS

#4061
20110130332
2011-06-02

Relaxin analogs

#4062
20110129527
2011-06-02

RAB3B for treatment and prevention of Parkinson's disease

#4063
20110129457
2011-06-02

Variant Hhip1 protein and methods and uses thereof

#4064
20110124843
2011-05-26

METHOD FOR EFFICIENTLY AMPLIFYING ABNORMAL PRION PROTEIN DERIVED FROM BSE

#4065
20110124714
2011-05-26

pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof

#4066
20110124574
2011-05-26

RESTORATION OF ESTROGEN RECEPTOR-(ALPHA) ACTIVITY

#4067
20110124554
2011-05-26

Fibrosuppressant Biotherapeutics

#4068
20110124080
2011-05-26

Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells

#4069
20110124016
2011-05-26

Diagnosis and Treatment of Malignant Neoplasms

#4070
20110123561
2011-05-26

METHODS AND COMPOSITIONS FOR INDUCTION OR PROMOTION OF IMMUNE TOLERANCE

#4071
20110123553
2011-05-26

Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination

#4072
20110123548
2011-05-26

COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF IMMUNE DISORDERS

#4073
20110123539
2011-05-26

NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 151P3D4 USEFUL IN TREATMENT AND DETECTION OF CANCER

#4074
20110123492
2011-05-26

Method for inducing immunity with a peptide fragment from human CAPRIN-1

#4075
20110119780
2011-05-19

SCREENING FOR NON-GENOTOXIC CARCINOGENS

#4076
20110117558
2011-05-19

DIAGNOSIS OF HEREDITARY SPASTIC PARAPLEGIAS (HSP) BY IDENTIFICATION OF A MUTATION IN THE ZFYVE26 GENE OR PROTEIN

#4077
20110117117
2011-05-19

Immunogenic epitopes for immunotherapy

#4078
20110117079
2011-05-19

Therapeutic DLL4 binding proteins

#4079
20110113864
2011-05-19

Identification of subjects being susceptible to anti-angiogenesis therapy

#4080
20110112280
2011-05-12

USE OF RGM AND ITS MODULATORS

#4081
20110112073
2011-05-12

Substituted pyrazoles as heat shock transcription factor activators

#4082
20110110952
2011-05-12

Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer

#4083
20110110938
2011-05-12

Compositions and methods for the treatment of immune related diseases

#4084
20110105998
2011-05-05

Systems, methods and compositions for optical stimulation of target cells

#4085
20110105718
2011-05-05

Nel-related type 1 polypeptide

#4086
20110105411
2011-05-05

Disease-Associated Proteins

#4087
20110104705
2011-05-05

Musclin receptor and use thereof

#4088
20110104668
2011-05-05

Nucleic acid ligands against infectious prions

#4089
20110104217
2011-05-05

Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands

#4090
20110104211
2011-05-05

Compositions and methods for the therapy and diagnosis of breast cancer

#4091
20110104170
2011-05-05

Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide

#4092
20110104169
2011-05-05

REGULATOR GENES OF ANGIOGENESIS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR APPLICATIONS

#4093
20110104063
2011-05-05

Flexibly labeling peptides

#4094
20110098448
2011-04-28

Anti-prion protein antibody fragment

#4095
20110098211
2011-04-28

Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the same

#4096
20110097803
2011-04-28

CLDN5 mini-promoters

#4097
20110097737
2011-04-28

Methods and Compositions for Targeting Proteins of Interest to the Host Cell Envelope

#4098
20110097330
2011-04-28

Novel Gene Disruptions, Compostitions and Methods Relating Thereto

#4099
20110097309
2011-04-28

Pharmaceutical Agent for Promoting the Functional Regeneration of Damaged Tissue

#4100
20110092434
2011-04-21

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

#4101
20110092414
2011-04-21

Composition for treating virus infection disease comprising Jab1

#4102
20110091878
2011-04-21

DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE

#4103
20110091876
2011-04-21

ZCYTOR19 POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE

#4104
20110087006
2011-04-14

DNA sequence encoding a retinoic acid regulated protein

#4105
20110086437
2011-04-14

METHODS TO INHIBIT CELL GROWTH

#4106
20110086042
2011-04-14

Centrosomal Proteins, Nucleic Acids and Method of Use Thereof

#4107
20110086028
2011-04-14

Method of inhibiting HIV-1 binding to genital epithelia using V3 loop-specific peptides and GP340-specific antibodies

#4108
20110082284
2011-04-07

Gene overexpressed in cancer

#4109
20110082093
2011-04-07

Engineered zinc finger proteins for treating trinucleotide repeat disorders

#4110
20110082082
2011-04-07

Skin wound healing compositions and methods of use thereof

#4111
20110081679
2011-04-07

Mammalian cell culture processes for protein production

#4112
20110081656
2011-04-07

Methods of identifying compounds that bind TANGO240

#4113
20110077387
2011-03-31

Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof

#4114
20110070653
2011-03-24

Inhibitor of histone acetyltransferase, especially p300

#4115
20110070614
2011-03-24

FUCOSE TRANSPORTER

#4116
20110070253
2011-03-24

TUMOUR-ASSOCIATED PEPTIDES BINDING TO MHC MOLECULES

#4117
20110070237
2011-03-24

Methods of modulating and identifying agents that modulate intracellular calcium

#4118
20110070236
2011-03-24

Use of immunesuppressant receptor

#4119
20110065649
2011-03-17

Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation

#4120
20110065646
2011-03-17

Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoprotein

#4121
20110065641
2011-03-17

POLYPEPTIDE AND DNA THEREOF USEFUL AS A NEOVASCULAR MARKER

#4122
20110065600
2011-03-17

Sequences associated with TDP-43 proteinopathies and methods of using the same

#4123
20110065587
2011-03-17

EPITOPE TESTING USING SOLUBLE HLA

#4124
20110065198
2011-03-17

Targets and compounds for therapeutic intervention of HIV infection

#4125
20110065177
2011-03-17

Novel Collectin

#4126
20110065124
2011-03-17

Methods of identifying compounds that bind TANGO509

#4127
20110064768
2011-03-17

Immunogenic Compositions

#4128
20110060124
2011-03-10

HLA-BINDING PEPTIDES, PRECURSORS THEREOF, DNA FRAGMENTS AND RECOMBINANT VECTORS THAT CODE FOR THOSE PEPTIDE SEQUENCES

#4129
20110059510
2011-03-10

TRANSGENIC RABBITS PRODUCING HUMAN FACTOR VII

#4130
20110059501
2011-03-10

Protein Glycosylation

#4131
20110059173
2011-03-10

Compositions and methods for promoting wound healing and tissue regeneration

#4132
20110059110
2011-03-10

Antibody (11C7) anti Nogo-A and its pharmaceutical use

#4133
20110059069
2011-03-10

Gapr-1 Methods

#4134
20110059068
2011-03-10

Polypeptides involved in immune response

#4135
20110055942
2011-03-03

Single domain TDF-related compounds and analogs thereof for use in treating a tissue differentiation factor related disorder

#4136
20110055939
2011-03-03

Methods for introducing a human gene into a marmoset embryo for making a transgenic marmoset

#4137
20110054148
2011-03-03

Antibodies to interferon-like protein Zcyto21(IL29)

#4138
20110053850
2011-03-03

Filipil compositions and methods for treating cancer

#4139
20110053787
2011-03-03

Compositions and Methods of Detecting Post-Stop Peptides

#4140
20110053217
2011-03-03

Polynucleotides encoding signal peptide-containing molecules

#4141
20110052501
2011-03-03

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS

#4142
20110052493
2011-03-03

HMGB1 high affinity binding domain Box-A mutants

#4143
20110046045
2011-02-24

Method of promoting apoptosis of differentiated adipocytes and increasing endogenous expression of SFRP-5 peptide by administration of SFRP-5 peptide

#4144
20110046042
2011-02-24

Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof

#4145
20110046038
2011-02-24

Polypeptide-polymer conjugates and methods of use thereof

#4146
20110045603
2011-02-24

Serine, Threonine, and Tyrosine Phosphorylation Sites

#4147
20110045590
2011-02-24

CALCIUM-INFLUX INHIBITORY FACTOR AND METHOD OF ISOLATION THEREOF

#4148
20110045495
2011-02-24

COMPOSITION AND METHOD FOR DIAGNOSIS OR DETECTION OF RENAL CANCER

#4149
20110044991
2011-02-24

METHODS AND COMPOSITIONS FOR TREATING LYMPHOMA AND MYELOMA

#4150
20110044974
2011-02-24

Peptide analogues comprising at least one type of aminoacylaza-$g(b)3and the use thereof, in particular for therapy

#4151
20110044921
2011-02-24

Substances and compositions for enhancing DNA repair and methods of use

#4152
20110039912
2011-02-17

Therapeutic agent for neuroblastoma targeting ARID3b

#4153
20110039783
2011-02-17

PEPTIDE HAVING HYPOTENSIVE ACTIVITY

#4154
20110039758
2011-02-17

Molecular Interactions in Neurons

#4155
20110039265
2011-02-17

Method of detecting tumor-associated DNA in plasma or serum from humans without cancer

#4156
20110038868
2011-02-17

Methods of treatment using antibodies to IL-17 homologous polypeptides

#4157
20110038025
2011-02-17

Circularly polarized light-emitting nanoparticle

#4158
20110034546
2011-02-10

Methods to produce rod-derived cone viability factor (RdCVF)

#4159
20110034370
2011-02-10

Bis-met histones

#4160
20110033866
2011-02-10

Resonance energy transfer assay with cleavage sequence and spacer

#4161
20110033467
2011-02-10

Methods of making an antibody that binds a chemerin polypeptide

#4162
20110028690
2011-02-03

Bag proteins and nucleic acid molecules encoding them

#4163
20110028403
2011-02-03

HSP70-Based Treatment for Autoimmune Diseases and Cancer

#4164
20110028398
2011-02-03

METHODS FOR TREATING AND LIMITING FIBROTIC DISORDERS AND KELOIDS

#4165
20110027909
2011-02-03

Chimera Compositions and Methods of Use

#4166
20110027806
2011-02-03

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

#4167
20110027299
2011-02-03

Melanoma antigens and their use in diagnostic and therapeutic methods

#4168
20110027176
2011-02-03

Homing peptide for tumor vasculature

#4169
20110021546
2011-01-27

Gene defects and mutant ALK kinase in human solid tumors

#4170
20110021444
2011-01-27

COMPOSITIONS FOR CONTROLLING HAIR GROWTH

#4171
20110020926
2011-01-27

DNA encoding a neoculin acidic subunit of curculin

#4172
20110020802
2011-01-27

Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia

#4173
20110020798
2011-01-27

Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor

#4174
20110020372
2011-01-27

FOLLISTATIN DOMAIN CONTAINING PROTEINS

#4175
20110020354
2011-01-27

Antibodies and functional fragments thereof that specifically bind an RF-amide peptide or a precursor thereof

#4176
20110020350
2011-01-27

Contraceptives Based on SP22 and SP22 Antibodies

#4177
20110020321
2011-01-27

Method of inhibiting binding or activity of MIF by administering a MIF antagonist

#4178
20110015127
2011-01-20

Targeting complement factor H for treatment of diseases

#4179
20110014675
2011-01-20

Poly zinc finger proteins with improved linkers

#4180
20110014651
2011-01-20

Method for high-level secretory production of protein

#4181
20110009604
2011-01-13

Method for Concentrating, Purifying and Removing Prion Protein

#4182
20110009337
2011-01-13

Q3 SPARC DELETION MUTANT AND USES THEREOF

#4183
20110009319
2011-01-13

Cripto antagonism of activin and TGF-b signaling

#4184
20110008311
2011-01-13

Animal Model and Use of 17Beta-Hydroxysteroid Dehydrogenase Type 7 in the Diagnosis of Anencephaly

#4185
20110008302
2011-01-13

Compositions and methods for immortalizing cells and screening for anti-cancer agents

#4186
20110003383
2011-01-06

Antibodies to HT5GJ57

#4187
20110003334
2011-01-06

Method for producing a cell for protein production by treating a cell overexpressing a taurine transporter with methotrexate

#4188
20110002941
2011-01-06

Antibodies that specifically bind hedgehog-derived polypeptides

#4189
20100333235
2010-12-30

Plant Centromere Compositions

#4190
20100331536
2010-12-30

CA125 gene and its use for diagnostic and therapeutic interventions

#4191
20100331262
2010-12-30

Peptide vaccine using mimic molecules of amyloid β peptide

#4192
20100331238
2010-12-30

Methods of screening for a compound that reduces atherogenesis

#4193
20100331206
2010-12-30

Compositions and methods for early pregnancy diagnosis

#4194
20100330697
2010-12-30

COMPLEXES OF TRPC DOMAINS AND SESTD1 DOMAINS AND METHODS AND USES INVOLVING THE SAME

#4195
20100330070
2010-12-30

Methods Of Making An Antibody And Compositions Thereof

#4196
20100330001
2010-12-30

Antibacterial compositions

#4197
20100329987
2010-12-30

Uses of Sperm Membrane Protein OBF

#4198
20100324829
2010-12-23

METHOD OF SELECTING HLA-DP4 LIGANDS AND THE APPLICATIONS THEREOF

#4199
20100324272
2010-12-23

Pancreatic cancer genes

#4200
20100324270
2010-12-23

Compositions and methods of use for modulators of polypeptides and polynucleotides in treating breast cancer and melanoma